海洋衍生藥物市場－全球產業規模、佔有率、趨勢、機會和預測，按類型、來源、應用、地區和競爭細分，2020-2030 年

2024 年全球海洋藥物市場價值為 124 億美元，預計在預測期內將實現令人印象深刻的成長，到 2030 年的複合年成長率為 9.10%。全球海洋藥物市場是製藥業的一個專業領域，利用來自海洋生物（包括藻類、海綿、珊瑚和海洋微生物）的生物活性化合物來開發創新療法。這些化合物具有獨特的藥理特性，可以製造出針對複雜醫療狀況的下一代藥物。

海洋生物技術的進步，特別是海洋基因組學和生物資訊學的進步，正在加速新型藥物的鑑定。這些突破解決了產業面臨的關鍵挑戰，例如抗菌素抗藥性和與傳統合成藥物相關的不良反應。此外，市場正在經歷向永續海洋生物探勘的策略轉變，藻類衍生化合物因其可擴展性和與全球永續發展計畫的一致性而成為主導領域。

主要市場促進因素

豐富的海洋生態系生物多樣性

主要市場挑戰

發現和開發成本高昂，

主要市場趨勢

基因組和宏基因組技術的進展

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第4章：顧客之聲

第5章：全球海洋衍生藥物市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 依類型（醚、胜肽、苯酚、類固醇）
  • 依來源（藻類、無脊椎動物、微生物）
  • 依應用（抗心血管、抗發炎、抗微生物、抗腫​​瘤、抗病毒）
  • 按地區
  • 按公司分類（2024）
• 產品市場圖
  • 按類型
  • 按來源
  • 按應用
  • 按地區

第6章：北美海洋藥物市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 加拿大
  • 墨西哥

第7章：歐洲海洋藥物市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 英國
  • 法國
  • 義大利
  • 西班牙

第8章：亞太海洋藥物市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 日本
  • 印度
  • 澳洲
  • 韓國

第9章：南美洲海洋藥物市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 阿根廷
  • 哥倫比亞

第10章：中東與非洲海洋藥物市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 科威特

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 近期發展
• 合併與收購
• 產品發布

第 13 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品的威脅

第 14 章：競爭格局

• Abbott Laboratories Inc
• Bayer AG
• Takeda Pharmaceutical Co Ltd
• Marine Polymer Technologies Inc
• Sanofi SA
• Aphios Corp
• Aker BioMarine ASA
• AbbVie Inc
• GSK PLCC

第 15 章：策略建議

第16章調查會社について,免責事項

Global Marine Derived Drugs Market was valued at USD 12.40 Billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 9.10% through 2030. The global marine-derived drugs market is a specialized segment of the pharmaceutical industry that leverages bioactive compounds from marine organisms-including algae, sponges, corals, and marine microorganisms-to develop innovative therapeutics. These compounds offer unique pharmacological properties, enabling the creation of next-generation drugs targeting complex medical conditions.

Advancements in marine biotechnology, particularly in marine genomics and bioinformatics, are accelerating the identification of novel pharmaceutical agents. These breakthroughs address critical industry challenges such as antimicrobial resistance and adverse effects linked to conventional synthetic drugs. Furthermore, the market is witnessing a strategic shift toward sustainable marine bioprospecting, with algae-derived compounds emerging as a dominant segment due to their scalability and alignment with global sustainability initiatives.

Key Market Drivers

Rich Biodiversity of Marine Ecosystems

The vast and diverse ecosystems of the world's oceans serve as an untapped reservoir of bioactive compounds with immense pharmaceutical potential. The rich biodiversity of marine environments is a key driver behind the expansion of the global marine-derived drugs market, fueling novel drug discovery and commercialization.

Marine ecosystems, spanning more than 70% of the Earth's surface, serve as a vast reservoir of biologically active compounds. These environments host a diverse array of microorganisms, invertebrates, and marine plants, many of which produce structurally unique secondary metabolites. These bioactive compounds are increasingly recognized for their potential in pharmaceutical innovation, offering novel therapeutic mechanisms that differentiate them from traditional synthetic drugs. These bioactive compounds, evolved over millions of years, exhibit structural complexity and pharmacological properties that are rarely found in terrestrial organisms. Marine-derived molecules such as peptides, alkaloids, polyketides, and terpenoids have demonstrated anti-cancer, anti-inflammatory, antimicrobial, and neuroprotective activities. Unlike terrestrial organisms, marine species thrive in extreme conditions (deep-sea trenches, hydrothermal vents, Arctic waters), leading to the evolution of highly potent and stable bioactive compounds that can withstand diverse physiological environments in drug formulations. This unparalleled chemical diversity positions marine ecosystems as high-value resources for next-generation pharmaceuticals targeting diseases with limited treatment options.

Key Market Challenges

High Cost of Discovery and Development and

One of the most significant challenges in the marine-derived drugs market is the high cost associated with the discovery and development of new drugs. The process of identifying, isolating, and testing marine compounds is time-consuming and resource intensive. Researchers often require specialized equipment and access to remote marine environments, which adds to the overall expense.

Key Market Trends

Advancements in Genomic and Metagenomic Technologies

Genomic and metagenomic technologies are revolutionizing marine drug discovery. By analyzing the DNA of marine organisms and their symbiotic microorganisms, researchers can identify potential drug candidates more efficiently. These techniques enable the discovery of previously hidden bioactive compounds and hold the promise of accelerating drug development.

Key Market Players

• Abbott Laboratories Inc
• Bayer AG
• Takeda Pharmaceutical Co Ltd
• Marine Polymer Technologies Inc
• Sanofi SA
• Aphios Corp
• Aker BioMarine ASA
• AbbVie Inc
• GSK PLC

Report Scope:

In this report, the Global Marine Derived Drugs Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Marine Derived Drugs Market, By Type:

• Ether
• Peptide
• Phenol
• Steroid

Marine Derived Drugs Market, By Source:

• Algae
• Invertebrates
• Microorganisms

Marine Derived Drugs Market, By Application:

• Anti-Cardiovascular
• Anti-Inflammatory
• Anti-Microbial
• Anti-Tumor
• Anti-Viral

Marine Derived Drugs Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Marine Derived Drugs Market.

Available Customizations:

Global Marine Derived Drugs market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Marine Derived Drugs Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Ether, Peptide, Phenol, Steroid)
  • 5.2.2. By Source (Algae, Invertebrates, Microorganisms)
  • 5.2.3. By Application (Anti-Cardiovascular, Anti-Inflammatory, Anti-Microbial, Anti-Tumor, Anti-Viral)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Product Market Map
  • 5.3.1. By Type
  • 5.3.2. By Source
  • 5.3.3. By Application
  • 5.3.4. By Region

6. North America Marine Derived Drugs Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type (Ether, Peptide, Phenol, Steroid)
  • 6.2.2. By Source (Algae, Invertebrates, Microorganisms)
  • 6.2.3. By Application (Anti-Cardiovascular, Anti-Inflammatory, Anti-Microbial, Anti-Tumor, Anti-Viral)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Marine Derived Drugs Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Source
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada Marine Derived Drugs Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Source
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico Marine Derived Drugs Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Source
      • 6.3.3.2.3. By Application

7. Europe Marine Derived Drugs Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type (Ether, Peptide, Phenol, Steroid)
  • 7.2.2. By Source (Algae, Invertebrates, Microorganisms)
  • 7.2.3. By Application (Anti-Cardiovascular, Anti-Inflammatory, Anti-Microbial, Anti-Tumor, Anti-Viral)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Marine Derived Drugs Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Source
      • 7.3.1.2.3. By Application
  • 7.3.2. United Kingdom Marine Derived Drugs Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Source
      • 7.3.2.2.3. By Application
  • 7.3.3. France Marine Derived Drugs Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Source
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Marine Derived Drugs Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Source
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Marine Derived Drugs Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Source
      • 7.3.5.2.3. By Application

8. Asia-Pacific Marine Derived Drugs Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type (Ether, Peptide, Phenol, Steroid)
  • 8.2.2. By Source (Algae, Invertebrates, Microorganisms)
  • 8.2.3. By Application (Anti-Cardiovascular, Anti-Inflammatory, Anti-Microbial, Anti-Tumor, Anti-Viral)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Marine Derived Drugs Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Source
      • 8.3.1.2.3. By Application
  • 8.3.2. Japan Marine Derived Drugs Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Source
      • 8.3.2.2.3. By Application
  • 8.3.3. India Marine Derived Drugs Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Source
      • 8.3.3.2.3. By Application
  • 8.3.4. Australia Marine Derived Drugs Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Source
      • 8.3.4.2.3. By Application
  • 8.3.5. South Korea Marine Derived Drugs Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Source
      • 8.3.5.2.3. By Application

9. South America Marine Derived Drugs Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type (Ether, Peptide, Phenol, Steroid)
  • 9.2.2. By Source (Algae, Invertebrates, Microorganisms)
  • 9.2.3. By Application (Anti-Cardiovascular, Anti-Inflammatory, Anti-Microbial, Anti-Tumor, Anti-Viral)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Marine Derived Drugs Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Source
      • 9.3.1.2.3. By Application
  • 9.3.2. Argentina Marine Derived Drugs Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Source
      • 9.3.2.2.3. By Application
  • 9.3.3. Colombia Marine Derived Drugs Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Source
      • 9.3.3.2.3. By Application

10. Middle East and Africa Marine Derived Drugs Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type (Ether, Peptide, Phenol, Steroid)
  • 10.2.2. By Source (Algae, Invertebrates, Microorganisms)
  • 10.2.3. By Application (Anti-Cardiovascular, Anti-Inflammatory, Anti-Microbial, Anti-Tumor, Anti-Viral)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Marine Derived Drugs Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Source
      • 10.3.1.2.3. By Application
  • 10.3.2. Saudi Arabia Marine Derived Drugs Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Source
      • 10.3.2.2.3. By Application
  • 10.3.3. UAE Marine Derived Drugs Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Source
      • 10.3.3.2.3. By Application
  • 10.3.4. Kuwait Marine Derived Drugs Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Type
      • 10.3.4.2.2. By Source
      • 10.3.4.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Abbott Laboratories Inc
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Bayer AG
• 14.3. Takeda Pharmaceutical Co Ltd
• 14.4. Marine Polymer Technologies Inc
• 14.5. Sanofi SA
• 14.6. Aphios Corp
• 14.7. Aker BioMarine ASA
• 14.8. AbbVie Inc
• 14.9. GSK PLCC

15. Strategic Recommendations

16. About Us & Disclaimer